Principal. Investigator also serves as the contact person for Bayer and CRO with regard to the Study at the Center. 2.4 Center shall allow and agrees that Principal Investigator, Investigators and other personnel involved with the Study (hereinafter referred to as “Study Team Members”) carry out the Study in compliance with the terms and conditions of this Agreement. Principal Investigator shall ensure that initial and
Principal. Investigator also serves as the contact person for Bayer and CRO with regard to the Study at the Center. 2.4 Center shall allow and the Principal Investigator shall ensure that Investigators and other personnel involved with the Study (hereinafter referred to as “Study Team Members”) comply with the terms and conditions of this Agreement. Center shall ensure through the Principal Investigator that initial and joining Study Team Members are appropriately trained, qualified and educated, in particular that they participate in all training sessions regarding the Study. Bayer shall have the right to reject specific Study Team Members on reasonable grounds, if Bayer deems them not appropriately trained and/or qualified. 2.5 Center shall allow Principal Investigator, Investigators and Study Team Members, as required, to participate in the investigator meetings and telephone conferences conducted in the course of the Study to the extent requested by Bayer. 2.6 Any subcontracting of any of Center’s obligations under this Agreement to a third party requires a prior written permission by Bayer, the granting of which shall be within Bayer’s sole discretion. Center shall in case of subcontracting (i) be responsible to enter into a written agreement with the subcontractor containing terms that (a) are similar to the terms
Principal. Investigator also serves as the contact person for Bayer and CRO with
Principal. Investigator also serves as the contact person for Bayer with regard to the Study at the Center. 2.4 Center shall allow and the Principal Investigator shall ensure that Investigators and other personnel involved with the Study (hereinafter referred to as “Study Team Members”) comply with the terms and conditions of this Agreement. Center shall ensure through the Principal Investigator that initial and joining Study Team Members are appropriately trained, qualified and educated, in particular that they participate in all training sessions regarding the Study. Bayer shall have the right to reject specific Study Team Members on reasonable grounds, if